466 related articles for article (PubMed ID: 30826225)
1. Assessment of Early Radiation-Induced Changes in Left Ventricular Function by Myocardial Strain Imaging After Breast Radiation Therapy.
Yu AF; Ho AY; Braunstein LZ; Thor ME; Lee Chuy K; Eaton A; Mara E; Cahlon O; Dang CT; Oeffinger KC; Steingart RM; Liu JE
J Am Soc Echocardiogr; 2019 Apr; 32(4):521-528. PubMed ID: 30826225
[TBL] [Abstract][Full Text] [Related]
2. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer.
Arciniegas Calle MC; Sandhu NP; Xia H; Cha SS; Pellikka PA; Ye Z; Herrmann J; Villarraga HR
BMC Cancer; 2018 Oct; 18(1):1037. PubMed ID: 30359235
[TBL] [Abstract][Full Text] [Related]
3. Persistent reduction in global longitudinal strain in the longer term after radiation therapy in patients with breast cancer.
Trivedi SJ; Choudhary P; Lo Q; Sritharan HP; Iyer A; Batumalai V; Delaney GP; Thomas L
Radiother Oncol; 2019 Mar; 132():148-154. PubMed ID: 30414755
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer.
Yu AF; Manrique C; Pun S; Liu JE; Mara E; Fleisher M; Patil S; Jones LW; Steingart RM; Hudis CA; Dang CT
Oncologist; 2016 Apr; 21(4):418-24. PubMed ID: 26984450
[TBL] [Abstract][Full Text] [Related]
5. Early detection of subclinical left ventricular dysfunction after breast cancer radiation therapy using speckle-tracking echocardiography: association between cardiac exposure and longitudinal strain reduction (BACCARAT study).
Walker V; Lairez O; Fondard O; Pathak A; Pinel B; Chevelle C; Franck D; Jimenez G; Camilleri J; Panh L; Broggio D; Derreumaux S; Bernier MO; Laurier D; Ferrières J; Jacob S
Radiat Oncol; 2019 Nov; 14(1):204. PubMed ID: 31727075
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal changes of right ventricular deformation mechanics during trastuzumab therapy in breast cancer patients.
Keramida K; Farmakis D; Bingcang J; Sulemane S; Sutherland S; Bingcang RA; Ramachandran K; Tzavara C; Charalampopoulos G; Filippiadis D; Kouris N; Nihoyannopoulos P
Eur J Heart Fail; 2019 Apr; 21(4):529-535. PubMed ID: 30811091
[TBL] [Abstract][Full Text] [Related]
7. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy.
Fallah-Rad N; Walker JR; Wassef A; Lytwyn M; Bohonis S; Fang T; Tian G; Kirkpatrick ID; Singal PK; Krahn M; Grenier D; Jassal DS
J Am Coll Cardiol; 2011 May; 57(22):2263-70. PubMed ID: 21616287
[TBL] [Abstract][Full Text] [Related]
8. Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy.
Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Clarke JL; Thomas L
Eur Heart J Cardiovasc Imaging; 2013 Mar; 14(3):228-34. PubMed ID: 22782955
[TBL] [Abstract][Full Text] [Related]
9. Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab.
Tan TC; Bouras S; Sawaya H; Sebag IA; Cohen V; Picard MH; Passeri J; Kuter I; Scherrer-Crosbie M
J Am Soc Echocardiogr; 2015 May; 28(5):509-14. PubMed ID: 25772019
[TBL] [Abstract][Full Text] [Related]
10. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab.
Sawaya H; Sebag IA; Plana JC; Januzzi JL; Ky B; Tan TC; Cohen V; Banchs J; Carver JR; Wiegers SE; Martin RP; Picard MH; Gerszten RE; Halpern EF; Passeri J; Kuter I; Scherrer-Crosbie M
Circ Cardiovasc Imaging; 2012 Sep; 5(5):596-603. PubMed ID: 22744937
[TBL] [Abstract][Full Text] [Related]
11. Diastolic Dysfunction Occurs Early in HER2-Positive Breast Cancer Patients Treated Concurrently With Radiation Therapy and Trastuzumab.
Cao L; Cai G; Chang C; Miao AY; Yu XL; Yang ZZ; Ma JL; Zhang Q; Wu J; Guo XM; Chen JY
Oncologist; 2015 Jun; 20(6):605-14. PubMed ID: 25933931
[TBL] [Abstract][Full Text] [Related]
12. Cardiac Magnetic Resonance Imaging and Blood Biomarkers for Evaluation of Radiation-Induced Cardiotoxicity in Patients With Breast Cancer: Results of a Phase 2 Clinical Trial.
Speers C; Murthy VL; Walker EM; Glide-Hurst CK; Marsh R; Tang M; Morris EL; Schipper MJ; Weinberg RL; Gits HC; Hayman J; Feng M; Balter J; Moran J; Jagsi R; Pierce LJ
Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):417-425. PubMed ID: 34509552
[TBL] [Abstract][Full Text] [Related]
13. Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy.
Erven K; Florian A; Slagmolen P; Sweldens C; Jurcut R; Wildiers H; Voigt JU; Weltens C
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1172-8. PubMed ID: 23149005
[TBL] [Abstract][Full Text] [Related]
14. No Acute Changes in LVEF Observed With Concurrent Trastuzumab and Breast Radiation With Low Heart Doses.
Bian SX; Korah MP; Whitaker TR; Ji L; Groshen S; Chung E
Clin Breast Cancer; 2017 Nov; 17(7):510-515. PubMed ID: 28412326
[TBL] [Abstract][Full Text] [Related]
15. Speckle tracking echocardiography predicts early subclinical anthracycline cardiotoxicity in patients with breast cancer.
Tang Q; Jiang Y; Xu Y; Xia H
J Clin Ultrasound; 2017 May; 45(4):222-230. PubMed ID: 27910996
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.
Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Byth K; Stuart K; Clarke JL; Thomas L
Eur J Cancer; 2013 Nov; 49(16):3396-403. PubMed ID: 23937961
[TBL] [Abstract][Full Text] [Related]
17. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study.
Ho E; Brown A; Barrett P; Morgan RB; King G; Kennedy MJ; Murphy RT
Heart; 2010 May; 96(9):701-7. PubMed ID: 20424152
[TBL] [Abstract][Full Text] [Related]
18. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients.
Sawaya H; Sebag IA; Plana JC; Januzzi JL; Ky B; Cohen V; Gosavi S; Carver JR; Wiegers SE; Martin RP; Picard MH; Gerszten RE; Halpern EF; Passeri J; Kuter I; Scherrer-Crosbie M
Am J Cardiol; 2011 May; 107(9):1375-80. PubMed ID: 21371685
[TBL] [Abstract][Full Text] [Related]
19. Utility of tissue Doppler and strain rate imaging in the early detection of trastuzumab and anthracycline mediated cardiomyopathy.
Jassal DS; Han SY; Hans C; Sharma A; Fang T; Ahmadie R; Lytwyn M; Walker JR; Bhalla RS; Czarnecki A; Moussa T; Singal PK
J Am Soc Echocardiogr; 2009 Apr; 22(4):418-24. PubMed ID: 19269133
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Cardiovascular Magnetic Resonance Tissue Characterization and Cardiotoxicity in Women With Breast Cancer.
Thavendiranathan P; Shalmon T; Fan CS; Houbois C; Amir E; Thevakumaran Y; Somerset E; Malowany JM; Urzua-Fresno C; Yip P; McIntosh C; Sussman MS; Brezden-Masley C; Yan AT; Koch CA; Spiller N; Abdel-Qadir H; Power C; Hanneman K; Wintersperger BJ
JAMA Cardiol; 2023 Jun; 8(6):524-534. PubMed ID: 37043251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
